ABDUL HADI KAAKOUR
Allopathic & Osteopathic Physicians|Ophthalmology NASHVILLE, TN NPI 1487004396
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology TN Genentech, Inc. All categories
General Payments — all program years on this page
$5,874.00
- Category: General Payments
- Program years: PY2018–2024
- Record count: 75
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $266.32 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.32 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech, Inc. | $143.34 | 3 |
| Apellis Pharmaceuticals, Inc. | $51.67 | 2 |
| Alimera Sciences, Inc. | $40.75 | 2 |
| Genentech USA, Inc. | $30.56 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092837691 | Alimera Sciences, Inc. | $25.39 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092841275 | Alimera Sciences, Inc. | $15.36 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132971809 | Genentech USA, Inc. | $30.56 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132971811 | Genentech, Inc. | $53.66 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132971813 | Genentech, Inc. | $22.73 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132971815 | Genentech, Inc. | $66.95 | 11/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154016012 | Apellis Pharmaceuticals, Inc. | $26.57 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154016014 | Apellis Pharmaceuticals, Inc. | $25.10 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.